厚朴 Magnolia Bark Extract × 睡眠品質
結論：證據支持但有警示
1 soft warning(s) — 自動發布但 UI 顯示 ⚠
C 🟠 C 薄弱證據 附警語發布 ✨ low — community discussion mostly non-commercial
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.42
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 附警語發布
信心度
78%
證據方向大致一致
證據層級
E7
單篇小型隨機對照試驗
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.418
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABAA receptor in mice
結論：At 20 mg/kg honokiol shortened NREM sleep latency and increased NREM sleep ~3.8-fold over 4h without altering NREM EEG delta power (p<0.01).
前往 PubMed
Oral Delivery of Honokiol Microparticles for Nonrapid Eye Movement Sleep
結論：Oral honokiol microparticles promoted NREM sleep in mice, supporting GABAA-mediated sleep mechanism via an oral route.
前往 PubMed
Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial
結論：Sleep quality and latency were NOT significantly changed by Relora vs placebo (anxiety reduced; 26/40 completers).
前往 PubMed
L4a US FDA
謹慎
The claims on your website establish that these products are drugs under section 201(g)(1) of the FD&C Act ... because they are intended for use in the cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. 來源↗
L4b EU EFSA
未表態
— 本適應症無對應資料
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
未表態
厚朴收載於《臺灣中藥典》,屬中藥材;未列入衛福部中醫藥司公告之「可同時提供食品使用之中藥材」清單。 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
未表態
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
— 本適應症無對應資料
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 低度
低中高
📍立場總覽
台灣社群（PTT 健身/Health/e-shopping/WomenTalk、Dcard、Mobile01、痞客邦）關於睡眠的保健品討論集中於 GABA、芝麻素、褪黑激素、鈣鎂鋅、色胺酸等成分，幾乎找不到以「厚朴」或「厚朴酚／和厚朴酚（honokiol）」作為助眠保健品的實測心得或買賣討論。市面 honokiol 產品多為國外品牌（EcoNugenics、Allergy Research Group、Life Extension），未見台灣社群流通與討論。屬在台社群極冷門品項，無在地討論可萃取。
💬社群實感
無共識（社群幾乎無相關討論）
- 失眠認知行為治療（CBT-I）
- 睡眠衛生與規律作息
- 規律運動
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-sleep-quality-INT-magnolia-bark-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "厚朴能改善睡眠品質",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}